Desq Long
Sign in

Company

Xeris Biopharma Holdings, Inc.

XERS · CIK 0001867096

SEC FORM 4
$141,434.34

Xeris Biopharma Holdings, Inc. (XERS)

Sale of 16,666 shares at $8.4864 per share.

Reporting Person Hecht Beth · Officer Title See Remarks · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001652410-26-000018 · filed 2026-09-01 · View filing →

SEC FORM 4
$42,500.00

Xeris Biopharma Holdings, Inc. (XERS)

Sale of 5,000 shares at $8.50 per share.

Reporting Person Pieper Steven · Officer Title See Remarks · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001875714-26-000012 · filed 2026-09-01 · View filing →

SEC FORM 4
$127,308.00

Xeris Biopharma Holdings, Inc. (XERS)

Sale of 15,000 shares at $8.4872 per share.

Reporting Person McCulloch Kevin · Officer Title See Remarks · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0002031695-26-000011 · filed 2026-09-01 · View filing →

SEC FORM 4
$177,097.44

Xeris Biopharma Holdings, Inc. (XERS)

Disposition (code F) of 21,918 shares at $8.08 per share.

Reporting Person McCulloch Kevin · Officer Title See Remarks · Transaction Code F

Traded Aug 1, 2026 · Disclosed Aug 21, 2026FILED +20 DAYS

Source: SEC Form 4 · 0001867096-26-000069 · filed 2026-08-21 · View filing →

SEC FORM 4
$296,091.60

Xeris Biopharma Holdings, Inc. (XERS)

Disposition (code F) of 36,645 shares at $8.08 per share.

Reporting Person Shannon John Patrick Jr · Officer Title See Remarks · Transaction Code F

Traded Aug 1, 2026 · Disclosed Aug 21, 2026FILED +20 DAYS

Source: SEC Form 4 · 0001867096-26-000073 · filed 2026-08-21 · View filing →

SEC FORM 4
$42,500.00

Xeris Biopharma Holdings, Inc. (XERS)

Sale of 5,000 shares at $8.50 per share.

Reporting Person Pieper Steven · Officer Title See Remarks · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001875714-26-000009 · filed 2026-08-12 · View filing →